HEL-12 virus: general considerations.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000502:physiology; D000956:Antigens, Viral / Q000032:analysis; D002415:Cats; D002472:Cell Transformation, Viral; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006736:Horses; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000276:immunology; D008253:Macaca mulatta; D051379:Mice; D010215:Papio; D011817:Rabbits; D012091:Repetitive Sequences, Nucleic Acid; D012190:Retroviridae / Q000276:immunology / Q000472:pathogenicity / Q000502:physiology; D018894:Reverse Transcriptase Inhibitors; D014412:Tumor Virus Infections / Q000150:complications* / Q000382:microbiology; D014759:Viral Envelope Proteins / Q000032:analysis; D014779:Virus Replication
D000914:Antibodies, Viral; D000956:Antigens, Viral; D018894:Reverse Transcriptase Inhibitors; D014759:Viral Envelope Proteins